DOSSIER · 13F Holders · Q1 2026
CTMX
CYTOMX THERAPEUTICS INC
182 institutions still hold CYTOMX THERAPEUTICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 23284F105·182 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
Assenagon Asset Management held its 364,173-share cornerstone stake in CytomX Therapeutics completely firm during Q2 2026, commanding over 40% of the micro-cap biotech’s $3.38 million institutional roster. China Universal also expanded its holding by 17.4% ($35.9k flow).
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 10
162 more holders available. Log in →